These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Oncologic resection for malignant tumors of the liver. Agrawal S; Belghiti J Ann Surg; 2011 Apr; 253(4):656-65. PubMed ID: 21475004 [TBL] [Abstract][Full Text] [Related]
26. Y90 selective internal radiation therapy. Lee EW; Thakor AS; Tafti BA; Liu DM Surg Oncol Clin N Am; 2015 Jan; 24(1):167-85. PubMed ID: 25444474 [TBL] [Abstract][Full Text] [Related]
27. Evidence-based integration of selective internal radiation therapy into the management of breast cancer liver metastases. Cianni R; Pelle G Future Oncol; 2014 Nov; 10(15 Suppl):93-5. PubMed ID: 25478777 [No Abstract] [Full Text] [Related]
28. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. Salem R; Thurston KG J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462 [TBL] [Abstract][Full Text] [Related]
29. Evidence-based integration of selective internal radiation therapy into the management of ocular melanoma liver metastases. Stedman B Future Oncol; 2014 Nov; 10(15 Suppl):97-100. PubMed ID: 25478778 [No Abstract] [Full Text] [Related]
30. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives]. Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591 [TBL] [Abstract][Full Text] [Related]
31. Evidence-based integration of selective internal radiation therapy into hepatocellular carcinoma management. Sangro B Future Oncol; 2014 Nov; 10(15 Suppl):7-11. PubMed ID: 25478760 [No Abstract] [Full Text] [Related]
32. Radioembolization for hepatocellular carcinoma. Sangro B; Iñarrairaegui M; Bilbao JI J Hepatol; 2012 Feb; 56(2):464-73. PubMed ID: 21816126 [TBL] [Abstract][Full Text] [Related]
33. Resection strategies for hepatocellular carcinoma. Wong TC; Lo CM Semin Liver Dis; 2013 Aug; 33(3):273-81. PubMed ID: 23943107 [TBL] [Abstract][Full Text] [Related]
34. How does selective internal radiation therapy compare with and/or complement other liver-directed therapies. Bargellini I Future Oncol; 2014 Nov; 10(15 Suppl):105-9. PubMed ID: 25478780 [No Abstract] [Full Text] [Related]
36. Latest selective internal radiation therapy recommendations from EU proctors. Maleux G Future Oncol; 2014 Nov; 10(15 Suppl):69-72. PubMed ID: 25478772 [No Abstract] [Full Text] [Related]
37. Selective internal radiation therapy: 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic). Uthappa MC; Ravikumar R; Gupta A Indian J Cancer; 2011; 48(1):18-23. PubMed ID: 21330750 [TBL] [Abstract][Full Text] [Related]
38. Laparoscopic liver resection: lessons at the end of the second decade. Afaneh C; Kluger MD Semin Liver Dis; 2013 Aug; 33(3):226-35. PubMed ID: 23943103 [TBL] [Abstract][Full Text] [Related]
39. Primary epithelial hepatic malignancies: etiology, epidemiology, and outcome after subtotal and total hepatic resection. Nagorney DM; Gigot JF Surg Oncol Clin N Am; 1996 Apr; 5(2):283-300. PubMed ID: 9019352 [TBL] [Abstract][Full Text] [Related]
40. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. Salem R; Thurston KG J Vasc Interv Radiol; 2006 Oct; 17(10):1571-93. PubMed ID: 17056999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]